Guangdong Jiabo Pharmaceutical Co., Ltd.

Guangdong Jiabo Pharmaceutical co., Ltd., founded in 2003, is an innovative high-tech pharmaceutical enterprise that integrates R&D, manufacturing, and sales, with a focus on the perioperative field and special injectables. With a strong 20-year track record, JIABO has established itself as a key player in both emerging and developed markets. The company employs over 500 people and improves the health of patients in more than 15 countries through its reliable, affordable medicines. Having built deep expertise in anesthesia, JIABO is a leading domestic manufacturer and the national standard setter for Propofol Injectable Emulsion. The company has earned several prestigious recognitions, including being named one of China's "Most investment-Worthy Pharmaceutical Enterprises", "Most Growth-Oriented Technological Innovation Pharmaceutical Enterprises", "National Intellectual Property Advantage Enterprises", "National Advanced Private Enterprises in Employment and Social Security", and a "Specialised, Refined, Featured, and Innovative SME". JIABO currently offers a range of perioperative anesthesia products, including Propofol Injectable Emulsion, Propofol Medium/Long Chain Fat Emulsion Injection, Ropivacaine Hydrochloride Injection, Flurbiprofen Axetil Injection, Methoxamine Hydrochloride Injection, Rocuronium Bromide Injection, Glycopyrrolate Injection and Medium and Long Chain Fat Emulsion Injection (C8-24Ve). These products cover key aspects such as anesthesia management, blood pressure stabilization, and secretion control during surgery, while also addressing postoperative pain relief and nutritional support, our product offers a comprehensive solution for perioperative clinical needs.